Intracellular Ca
2+ plays an important role in skeletal muscle excitation-contraction coupling and also in excitation-transcription coupling. Activity-dependent alterations in muscle gene expression as a result of increased load (i.e. resistance or endurance training) or decreased activity (i.e. immobilization or injury) are tightly linked to the level of muscle excitation. Differential expression of genes in slow-and fast-twitch fibres is also dependent on fibre activation. Both these biological phenomena are, therefore, tightly linked to the amplitude and duration of the Ca 2+ transient, a signal decoded downstream by Ca 2+ -dependent transcriptional pathways. Evidence is mounting that the calcineurin-nuclear factor of activated T-cells pathway and the Ca 2+ /calmodulin-dependent kinases (CaMK) II and IV play important roles in regulating oxidative enzyme expression, mitochondrial biogenesis and expression of fibre-type specific myofibrillar proteins. CaMKII is known to decode frequency-dependent information and is activated during hypertrophic growth and endurance adaptations. Thus, it was hypothesized that CaMKII, and possibly CaMKIV, are down regulated during muscle atrophy and levels of expression of CaMKIIa, -IIb, -IIg and -IV were assessed in skeletal muscles from young, aged and denervated rats. The results indicate that CaMKIIg, but not CaMKIIa or -b, is up regulated in aged and denervated soleus muscle and that CaMKIV is absent in skeletal but not cardiac muscle. Whether CaMKIIg up-regulation is part of the pathology of wasting or a result of some adaptational response to atrophy is not known. Future studies will be important in determining whether insights from the adaptational response of muscle to increased loads will provide pharmacological approaches for increasing muscle strength or endurance to counter muscle wasting.
Calcium ions: Ca
2+ /calmodulin-dependent kinase: Skeletal muscle: Mitochondrial biogenesis Intracellular Ca 2+ plays an important role in signal transduction in all cell types. In skeletal muscle it is well established that Ca 2+ plays an essential role in the contraction-relaxation cycle. More recently, the role of Ca 2+ in regulating activity-dependent muscle gene expression has been recognized as being important in muscle plasticity and in explaining muscle fibre type heterogeneity (Berchtold et al. 2000; . Neural activation of skeletal muscle results in the release of acetylcholine from the neuro-muscular junction and depolarization of the plasma membrane, which activates force production by a process known as excitation-contraction coupling (see Fig. 1 ). The frequency and duration of stimulation determine the amplitude and duration of the Ca 2+ transients and, as a result, the level of force output by the muscle (Westerblad & Allen, 1991) . Similarly, it is thought that the amplitude and duration of the Ca 2+ transient will also determine the set of genes expressed, thus providing a mechanism for tightly coupling the extent of muscle excitation to regulation of transcription (i.e. excitation-transcription coupling). It is this mechanism that may tightly link muscle gene expression to the activation history of the cell, thus providing a basis by which muscles can adapt, at the molecular level, to the functional demands placed on them.
Role of calcium signalling in excitation-contraction coupling and excitation-transcription coupling
It is well established that the preceding pattern of muscle excitation plays an important role in determining the pattern of genes expressed, and ultimately in the contractile behaviour of a given muscle (see Pette & Staron, 1997 ).
The classic cross-innervation experiments of Vrbova (1963) and models using neural or direct muscle stimulation to transform fast skeletal muscle to a slow type demonstrated that muscle fibres can alter their expression of contractile, metabolic and membrane-bound signalling proteins in response to altered input (for review, see Pette & Vrbova, 1992) . Physical activity, through increased loading (i.e. resistance training), increased repetitive stimulation (i.e. endurance training) or decreased physical activity as a result of disuse atrophy, injury or age-related muscle wasting can also alter skeletal muscle phenotype, which in turn is directly related to changes in the proteins expressed in individual fibres. While the ability to alter muscle fibre type characteristics has been well established over the past few decades, the molecular mechanism(s) underlying these adaptive responses are not as well understood. Likewise, the broad heterogeneity between skeletal muscle fibre types is well established. Muscles consist of two main fibre types, slow (type I or slow oxidative) and fast (type II or glycolytic with a varying range of oxidative potential), which vary in their contractile speed, metabolic profile and fatigue resistance. The main fibre types are determined by the myosin heavy chain isoform expressed (types I, IIa, IIx and IIb) and also by alterations in various myofibrillar proteins, including myosin light chains, troponin subunits I, T and C and tropomyosin. While the complement of fibre type-specific genes expressed in a slow fibre v. a fast fibre programme is well understood (see Schiaffino & Reggiani, 1996) , the regulatory signals that control differential gene expression between fibre types are less established. (Westerblad & Allen, 1991) . In contrast, when muscles are activated to contract, [Ca 2+ ] i reaches 100-300 nM (Chin & Allen, 1996) in slow-twitch (type I) fibres activated at frequencies of slow motor units (10-30 Hz; Hennig & Lomo 1985) , and even higher to 1-2 mM (Westerblad & Allen, 1991) in fast-twitch (types IIb and IIa) fibres activated at frequencies of fast motor units (80-150 Hz; Hennig & Lomo, 1985) . These dramatic increases in amplitude, as well as the duration for which these amplitudes are achieved, are thought to encode a signal that will be recognized by different downstream Ca 2+ -dependent transcriptional pathways. The key signalling pathways downstream of the elevation in intracellular Ca 2+ that translate this signal into a transcriptional response include the Ca 2+ -dependent phosphatase calcineurin (CnA; Chin et al. 1998; Naya et al. 2000; Wu et al. 2001) , Ca 2+ / calmodulin-dependent kinases (CaMK) II (Flück et al. 2000) and IV and Ca 2+ -dependent protein kinase C (PKC; Freyssenet et al. 1999; see Fig. 2) . The downstream target genes that are activated by these pathways are many. Ca 2+ -dependent changes in muscle gene expression have been demonstrated for the nicotinic acetylcholine receptor (Walke et al. 1994) , GLUT4 (Ojuka et al. 2002b) , sarcoplasmic reticulum Ca 2+ -transporting ATPase, myosin heavy chain isoforms (Allen et al. 2001; Allen & Leinwand, 2002) and oxidative enzymes, as well as genes that regulate mitochondrial biogenesis (Freyssenet et al. 1999; Ojuka et al. 2002a Ojuka et al. , 2003 Chin et al. 2003) . These genes are up-regulated (GLUT4; myosin heavy chain types IIa > > IId/x > IIb; mitochondrial enzymes cytochrome c, cyclooxygenase 1, 5-aminolevulinate synthase, succinate dehydrogenase) or down-regulated (nicotinic acetylcholine receptor, sarcoplasmic reticulum Ca 2+ -transporting ATPase) with increased contractile activity. These genes also have varied levels of expression between fibres that have high fatigue resistance (types I and IIa) and those of low fatigue resistance (type IIb), supporting the notion that the extent of muscle activation, through the resultant amplitude and duration of Ca ATP ADP + P i Fig. 1 . Skeletal muscle excitation-contraction and excitationtranscription coupling. Activation of muscle contraction results in depolarization of the plasma membrane and the transverse tubule (t-tubule) system. The t-tubule system carries the signal to the interior of the fibre where the voltage-sensing dihydropyridine receptor (DHPR) detects the change in membrane potential and transmits the signal to the calcium-release channel, also known as the ryanodine receptor (RYR). Release of calcium from the internal storage site (sarcoplasmic reticulum; SR) into the myoplasm results in actin-myosin interaction, fibre shortening and force production. Skeletal muscle calcium levels are also elevated by ligand-mediated activation of L-type calcium channels by signalling molecules such as insulin-like growth factor-I, which result in influx of calcium via the plasma membrane. Freyssenet et al. 1999; Ojuka et al. 2002a Ojuka et al. , 2003 . These studies show increased expression of mitochondrial enzymes at the mRNA and protein level, implicating a transcriptional response to elevated Ca 2+ . This transcriptional response has been verified using promoter reporter constructs (Freyssenet et al. 1999 ) that are activated in response to elevated [Ca 2+ ] i . Increased expression of transcription factors known to play a role in mitochondrial biogenesis, PPARg co-activator-1 (PGC-1), mitochondrial transcription factor A, and nuclear respiratory factors 1 and 2 (Ojuka et al. 2003) , further supports the role of Ca 2+ in regulating mitochondrial gene expression at the transcriptional level. In vivo studies with transgenic mice that overexpress or have disrupted expression of the Ca 2+ -buffering protein parvalbumin further support the Ca 2+ dependence of mitochondrial enzyme expression. Mice with increased expression of parvalbumin, and consequently attenuated levels of [Ca 2+ ] i in activated muscles, have decreased activity of succinate dehydrogenase, a mitochondrial marker enzyme . These data are consistent with the increased mitochondrial volume and cytochrome c oxidase activity observed in parvalbumin-deficient mice (Chen et al. 2001) . In both the parvalbumin-overexpression and parvalbumin-deficient mice alterations in muscle oxidative potential were independent of changes in myosin isoform, suggesting differential regulation of mitochondrial and contractile genes when [Ca 2+ ] i is regulated physiologically through altered Ca 2+ -regulatory proteins.
Role of the calcineurin-nuclear factor of activated T-cells pathway in skeletal muscle gene expression
It has been hypothesized that the CnA-nuclear factor of activated T-cells (NFAT) pathway plays an important role in decoding the Ca 2+ amplitude and duration signal to regulate genes differentially expressed in slow fibres v. fast fibres (Chin et al. 1998; Naya et al. 2000) . This pathway has also been shown to play an important role in the hypertrophic growth response in skeletal muscle (Dunn et al. 1999) as well as in cardiac muscle (Molkentin et al. 1998) . The CnA-NFAT pathway was first shown to be a decoder of the amplitude and duration of the Ca 2+ signal in T lymphocytes (Dolmetsch et al. 1997) transcriptional complex that activates IL-2 expression. The CnA-NFAT pathway is not, however, activated when Ca 2+ pulses reach high-amplitude peaks for short durations and thus does not stimulate IL-2 expression under these conditions. It has now been shown that the CnA-NFAT pathway is activated in single skeletal muscle fibres in a manner also dependent on the level of Ca 2+ elevation (Liu et al. 2001) . Liu et al. (2001) have shown that CnA-NFAT activation, as determined by NFAT nuclear localization, occurs in single adult muscle fibres in response to continuous stimulation at 10 Hz or to 5 s trains of 10 Hz stimuli every 50 s, a pattern representative of slow fibre recruitment. However, the CnA-NFAT pathway is not activated in response to continuous stimulation at 1 Hz or with trains of 50 Hz stimuli every 50 s, the latter of which is representative of a fast-fibre-type recruitment pattern. The nuclear localization of NFAT is inhibited by the CnA inhibitor cyclosporin, implicating the CnA-NFAT pathway.
There is mounting evidence in skeletal muscle that Ca 2+ signals through CnA and downstream through the transcription factors NFAT and myocyte-enhancing factor 2.
In cultured myotubes in vitro it has been shown that slowfibre-specific promoters (i.e. troponin I slow, myoglobin) containing NFAT-binding elements as well as myocyteenhancing factor 2-binding sites are differentially activated compared with fast-fibre-specific promoters that do not have NFAT elements (Chin et al. 1998) . Other investigators have suggested that NFAT and myocyte-enhancing factor 2 sites alone cannot account for the preferential activation of the myosin heavy chain isoform expressed in fast oxidative (type IIa) fibres and suggest that additional ciselements and putative transcription factors exist downstream of the Ca 2+ -CnA signal (Allen et al. 2001) . Studies in transgenic mice that overexpress an activated form of CnA (CnA*) in skeletal muscle further support the differential activation of slow and oxidative genes (Naya et al. 2000; Wu et al. 2001) . In these mice, muscles that express the transgene have higher levels of slow-twitch fibres and express proportionately higher levels of the slow oxidative fibre markers myoglobin, troponin I slow and sarcomeric mitochondrial creatine kinase; in contrast, they express relatively lower levels of the fast glycolytic fibre markers PV and muscle creatine kinase (Naya et al. 2000) . Furthermore, this response has been shown to be dosedependent (Wu et al. 2001) . Utrophin, an important component of the dystro-sarcoglycan complex that is important for maintaining sarcolemmal membrane integrity, is more highly expressed in slow oxidative fibres and this expression has recently been shown to be CnA-NFAT dependent (Chakkalakal et al. 2003) . Utrophin expression is up regulated in CnA* transgenic mice in the absence of changes in myosin heavy chain, indicating that this gene is regulated by CnA-NFAT signalling independent of muscle fibre type. In vivo studies with fast and slow muscle promoter constructs, however, do not support this differential activation of slow-fibre genes in response to activated CnA (Swoap et al. 2000) , and suggest that under endogenous regulation CnA is probably not the only regulator of fibre-type-specific gene expression.
Role of calcium/calmodulin-dependent kinases in regulating skeletal muscle gene expression
Other pathways shown to play an important role in the Ca 2+ -dependent regulation of muscle gene expression are the CaMK pathways. The CaMKII pathway has been shown to play an important role in activation of mitochondrial biogenesis and the regulation of oxidative enzyme expression as well as a muscle hypertrophy response (Flück et al. 2000) . The CaMKIV pathway has also been shown to play a role in mitochondrial biogenesis . Examination of Ca 2+ -dependent and Ca 2+ -independent CaMKII activity in muscles following 7 d of stretch overload and following 2 weeks of voluntary wheel running (Flück et al. 2000) has shown that stretch overload of chicken anterior latissimus dorsi muscle results in a 122% increase in muscle protein content and is associated with a 47% increase in Ca 2+ -independent CaMKII activity. Ca 2+ -dependent and total CaMKII activities are not increased, indicating that there is greater activation of the pre-existing CaMKII protein. Similarly, voluntary wheel running by Sprague-Dawley rats results in a 43 % increase in Ca 2+ -independent CaMKII activity with no increase in total CaMKII activity. CaMKII has been shown to phosphorylate serum response factor, which can bind to the serum response element and thus activate actin gene expression. The similarity in the response of CaMKII to endurance training and stretch overload suggests that this pathway is upstream of the specific adaptations to these contractile demands. Nonetheless, they do reflect an increase in CaMKII autonomous activity, indicating sustained activation of this Ca 2+ signalling pathway. CaMKII has been shown in other cell types, primarily neurons, to play an important role in decoding the frequency of Ca 2+ oscillations in transcriptional regulation (see Braun & Schulman, 1995; Soderling et al. 2001) . Synaptic plasticity, such as long-term potentiation, is triggered by increases in intracellular Ca 2+ and activation of CaMKII. The structural organization and molecular regulation of CaMKII allows the enzyme to decode the frequency of Ca 2+ spikes into distinct amounts of kinase activity and subsequently into graded levels of transcriptional activation. CaMKII is a multimeric enzyme composed of twelve subunits arranged in two sets of six subunits in a spoke and wheel pattern (see Braun & Schulman, 1995; Soderling et al. 2001) . The central hub portion contains the carboxy terminus association domain and the spoke portions contain the amino terminus catalytic domain and the intervening regulatory domains. When [Ca 2+ ] i is elevated, Ca 2+ associates with calmodulin, the Ca 2+ -calmodulin complex binds to the calmodulinbinding domain and activates intramolecular autophosphorylation, which results in autonomous (i.e. Ca 2+ independent) activity. Both the multimeric structure and its regulation by autophosphorylation allow this signalling molecule to titrate levels of kinase activity and therefore transcriptional activation in proportion to Ca 2+ oscillatory frequency, amplitude and duration. As a result of its functional role in neurons in decoding frequency-dependent information (De Koninck & Schulman, 1998) and its observed autophosphorylation following prolonged skeletal muscle activation (Fluck et al. 2000) , CaMKII is postulated to be the stimulation-frequency decoder in skeletal muscle.
Recent evidence also implicates CaMKIV in the Ca 2+ -dependent regulation of muscle gene expression, specifically in the activation of mitochondrial biogenesis and oxidative enzyme expression . Overexpression of a constitutively-active form of CaMKIV in mouse skeletal muscle results in increased mitochondrial volume, increased expression of both mitochondrial and nuclear DNA-encoded mitochondrial enzymes involved in fatty acid metabolism and electron transport, and enhanced recovery from fatigue . The mice also show a subtle (approximately 8%) increase in slow-twitch fibres. Although the downstream target(s) of CaMKIV has not been identified, it is known that cAMP-response element-binding protein is phosphorylated in CaMKIVmediated transcription in neurons and T-cells (Matthews et al. 1994) . The role of cAMP-response element-binding protein phosphorylation by CaMKIV in regulating skeletal muscle gene expression has not been examined. In CaMKIV transgenic mice the increase in mitochondrial content is, however, associated with increased expression of PGC-1, the master switch of mitochondrial biogenesis. Transgenic mice that overexpress PGC-1 in skeletal muscle also show a similar phenotype, with increased oxidative fibre content and increased expression of slow type I fibre genes (Lin et al. 2002) . Thus, CaMKIV appears to signal through PGC-1 to increase mitochondrial biogenesis in skeletal muscle. Interestingly, muscle energy depletion using a b-guanidinopropionic acid diet to deplete creatine phosphate stores results in increased PGC-1 and CaMKIV expression concomitant with mitochondrial biogenesis (Zong et al. 2002) . Under these conditions, up-regulation of CaMKIV and PGC-1 is dependent on AMP kinase activity, since AMP kinase-dominant negative mice do not show these mitochondrial adaptations with b-guanidinopropionic acid treatment (Zong et al. 2002) . It is likely that both the decrease in cellular ATP and the increase in intracellular Ca 2+ are responsible for signalling an increase in mitochondrial biogenesis and muscle oxidative capacity in response to repetitive muscle activation.
Calcium/calmodulin-dependent kinases as therapeutic drug targets
Based on the evidence implicating CaMK signalling in muscle fibre type determination, muscle oxidative capacity and muscle adaptation to overload hypertrophy and endurance activity, there is much interest in the potential role of CaMK modulators as a pharmacological approach for muscle myopathies. Conditions of muscle atrophy, including disuse atrophy, injury and age-related muscle wasting, may be attenuated with agonists of a target molecule such as CaMKII or CaMKIV that could increase strength or oxidative capacity. While CaMKIV appears to be a good candidate for pharmacological intervention, based on the biological response in mice to CaMKIV overexpression , its expression level in muscle is not well documented. CaMKII may also be a good target, but it is not clear which of its multiple isoforms is most important in skeletal muscle signalling. CaMK II isoforms arise from four different genes that are differentially expressed, with CaMKIIa and CaMKIIb expressed in neural tissue (Braun & Schulman, 1995) and muscle (Bayer et al. 1998) , and CaMKIIg and CaMKIId expressed ubiquitously (Braun & Schulman, 1995) . CaMKI has not been studied extensively in skeletal muscle, although it has been shown that activated CaMKI is equally as effective as CaMKIV in activating a myoglobin promoter whereas CaMKII does not transcriptionally activate myoglobin . Table 1 summarizes the major CaMK enzymes and their regulatory properties. Based on their biochemical properties and their potential biological role in skeletal muscle adaptation, the expression patterns of CaMKII and CaMKIV in skeletal muscle have been further examined; in particular, to determine whether CaMKII or CaMKIV expression levels are altered in age-related muscle wasting or in denervation atrophy. In skeletal muscle samples obtained from soleus (SOL), extensor digitorum longus or tibialis anterior muscles of young or aged (4 and 27 months respectively) Harlan Sprague-Dawley rats and from young rats after 20 d denervation, it has been found that by 27 months of age these rats show a 33% decrease in muscle mass and maximum tetanic force (C Ibebunjo, unpublished results). Analysis of CaMKII and CaMKIV mRNA levels (by RT-PCR using primers specific for the various CaMKII isoforms and for CaMKIV; see Fig. 3 legend) and CaMKII protein levels (by Western blot using antibodies obtained from Santa Cruz, Santa Cruz, CA, USA) has shown that CaMKIIa and CaMKIIb mRNA levels are not altered in SOL and extensor digitorum longus muscle from aged rats compared with young rats (Fig. 3) , but interestingly there are two CaMKIIb splice variants, one of which is expressed at lower levels in the fast-twitch extensor digitorum longus compared with the slow-twitch SOL. CaMKIV mRNA levels are not detectable in SOL or extensor digitorum longus under conditions (thirty cycles) in which mRNA is detected in heart and brain. The absence of evidence of CaMKIV expression in skeletal muscle is consistent with previous reports in the literature (see Matthews et al. 1994) . A recent report by Zong et al. (2002) is the first to show CaMKIV expression in skeletal muscle, but these data are inconsistent with the observations from the author's laboratory. Examination of the changes in CaMKII expression at the protein level using commercially-available antibodies has failed to detect either CaMKIIa or CaMKIIb; however, CaMKIIg has been detected and analysed in young, aged and denervated muscles. Fig. 4 shows that CaMKIIg is up regulated approximately 2-fold in aged and denervated SOL muscle. Since CaMKII is activated during a hypertrophic and endurance training response, it was hypothesized that CaMKII expression would be decreased during periods of muscle atrophy. These findings do not support this hypothesis and suggest that SOL muscle atrophy may activate a compensatory adaptive response to counter the ongoing muscle wasting. Alternatively, CaMKIIg protein levels could be increased despite decreased enzymic activity. Fig. 5 illustrates the changes in CaMKIIg protein levels in tibialis anterior muscle of aged and denervated animals. In contrast to the SOL, this muscle shows no change in protein expression with muscle atrophy. Thus, a compensatory adaptation appears to exist only in the slow oxidative muscles. Based on these observations it is not clear whether CaMKII or CaMKIV would be suitable targets for pharmacological intervention for muscle wasting pathologies. are achieved using pharmacological agents in cultured myocytes or the downstream pathways are activated by overexpression of exogenous genes in GM mice. In order to understand the role that these pathways play in vivo, the physiological relevance of these models needs to be considered. Pharmacological tools, primarily Ca 2+ ionophores (i.e. A23187 and ionomycin) and caffeine, have been shown to up-regulate slow-fibre-specific and oxidative genes. While this finding does implicate a Ca 2+ dependence of the transcriptional response, the cellular Fig. 3 . Calcium/calmodulin-dependent kinases (CaMK) II and IV mRNA expression in young and aged rat skeletal muscle. Soleus (SOL) and extensor digitorum longus (EDL) muscles were obtained from young (4 months) and aged (27 months) Sprage-Dawley rats. Total RNA was isolated using TriPure reagent (Roche, Basel, Switzerland) and 10 ng used to generate cDNA with Mulroney murine leukaemic virus RT in a 60 ml reaction. cDNA (5 ml) was amplified with Taq polymerase and the following CaMK primers: GAATGACAGCCTTTGAACCGG and TGCCATTTTCCATCCCTGC for CaMKIIa forward and reverse respectively; ATGCAAGG-AGGAAGCTCAAGG and TGGATAACGGTGGTTTGAGGC for CaMKIIb forward and reverse respectively; CAGGAAAAGCAGCC-AACTTTG and TAGCTTCATCGTCTCATCGGC for CaMKIV forward and reverse respectively. PCR conditions were 94xC for 3 min; 94xC for 30 s, 60xC for 1 min, 72xC for 1 min · thirty cycles; 72xC for 3 min. PCR products were run on agarose gels (8 ml/l) alongside a 1 kb + DNA standard. Bl, blank; Br, brain; HRT, heart. 
Summary
In summary, there is strong evidence that intracellular Ca 2+ signals in skeletal muscle are important not only in excitation-contraction coupling but also in excitationtranscription coupling. The specific signalling pathways that are activated in response to differing frequency, amplitude and duration of various Ca 2+ transients that signal to different downstream target genes are still not fully understood. Evidence is mounting that the CnA-NFAT pathway as well as CaMK pathways play important roles in activating mitochondrial biogenesis and, to a lesser extent, myosin and other contractile protein isoform expression. It is also clear that multiple signals may converge to fully activate an adaptational response. Transcriptional regulation through CnA-NFAT and CaMK pathways are synergistic (Wu et al. 2001) and Ca 2+ -dependent CaMK signals may be synergistic with ATP-dependent signalling through AMP kinase. Through this well-coordinated system of feedforward-and feedback-mediated signalling, skeletal muscles can optimally adapt to the loads placed on them and thus improve functional capacity to meet the demands of the imposed load.
months 27 months
Control Denervated Relative intensity Fig. 5 . Calcium/calmodulin-dependent kinases (CaMK) IIg protein expression in young, aged and denervated rat tibialis anterior muscle. Tibialis anterior were obtained from young (4 months) or aged (27 months) Sprague-Dawley rats and from young rats 20 d after sciatic nerve transection. Muscles were homogenized in a hypotonic lysis buffer (20 mM-Hepes, 10 mM-NaCl, 1 . 5 mM-MgCl 2 , 1 ml Triton X-100/l, 200 ml glycerol/l, 1 mM-dithiothreitol and protease inhibitors complete EDTA-free; Roche, Basel, Switzerland) and 10 mg samples were run on 4-12% Bis-Tris gels in 2-(N-morpholino)ethanesulfonic acid-SDS buffer. Protein was transferred onto a 0 . 45 mm nitrocellulose membrane and probed with anti-CaMKIIg antibody (Santa Cruz, Santa Cruz, CA, USA). Western blot images were quantified using a Fujifilm Imager (Fujifilm BAS2500; Fujifilm, Tokyo, Japan). Values are means and standard deviations represented by vertical bars for four samples. Differences between soleus muscle from aged and young rats and between control and denervated muscle were not statistically significant.
